119 related articles for article (PubMed ID: 32234942)
1. Clinical Outcomes and Prognostic Factors of Patients With Esophageal Squamous Cell Carcinoma With Oligo-recurrence Treated With Radical Re-irradiation.
Lin CY; Fang HY; Lein MY; Lin CC; Bai LY; Tsai MH; Chen CC; Hsieh TC; Wang YC; Liang JA; Li CC; Chien CR
Anticancer Res; 2020 Apr; 40(4):2387-2392. PubMed ID: 32234942
[TBL] [Abstract][Full Text] [Related]
2. The status of perineural invasion predicts the outcomes of postoperative radiotherapy in locally advanced esophageal squamous cell carcinoma.
Ning ZH; Zhao W; Li XD; Chen LJ; Xu B; Gu WD; Shao YJ; Xu Y; Huang J; Pei HL; Jiang JT
Int J Clin Exp Pathol; 2015; 8(6):6881-90. PubMed ID: 26261575
[TBL] [Abstract][Full Text] [Related]
3. Evaluating the optimal re-irradiation dose for locally recurrent esophageal squamous cell carcinoma after definitive radiotherapy.
Xu X; Wang Z; Jiang S; Shang Y; Wu Y
Radiat Oncol; 2019 Nov; 14(1):191. PubMed ID: 31684983
[TBL] [Abstract][Full Text] [Related]
4. Re-irradiation for oligo-recurrence from esophageal cancer with radiotherapy history: a multi-institutional study.
Jingu K; Niibe Y; Yamashita H; Katsui K; Matsumoto T; Nishina T; Terahara A
Radiat Oncol; 2017 Sep; 12(1):146. PubMed ID: 28870211
[TBL] [Abstract][Full Text] [Related]
5. A re-irradiation dose of 55-60 Gy improves the survival rate of patients with local recurrent esophageal squamous cell carcinoma after radiotherapy.
Wu X; Hu X; Chen J; He L
Radiat Oncol; 2021 Jun; 16(1):100. PubMed ID: 34103059
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the 7th edition of the TNM classification in patients with resected esophageal squamous cell carcinoma.
Wang J; Wu N; Zheng QF; Yan S; Lv C; Li SL; Yang Y
World J Gastroenterol; 2014 Dec; 20(48):18397-403. PubMed ID: 25561808
[TBL] [Abstract][Full Text] [Related]
7. Survival benefit of re-irradiation in esophageal Cancer patients with Locoregional recurrence: a propensity score-matched analysis.
Hong L; Huang YX; Zhuang QY; Zhang XQ; Tang LR; Du KX; Lin XY; Zheng BH; Cai SL; Wu JX; Li JL
Radiat Oncol; 2018 Sep; 13(1):171. PubMed ID: 30201005
[TBL] [Abstract][Full Text] [Related]
8. Primary mucoepidermoid carcinoma of the esophagus.
Chen S; Chen Y; Yang J; Yang W; Weng H; Li H; Liu D
J Thorac Oncol; 2011 Aug; 6(8):1426-31. PubMed ID: 21587086
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of HPV status in the re-irradiation of recurrent and second primary cancers of the head and neck.
Velez MA; Wang PC; Hsu S; Chin R; Beron P; Abemayor E; St John M; Chen AM
Am J Otolaryngol; 2018; 39(3):257-260. PubMed ID: 29433815
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and toxicity of re-irradiation for esophageal cancer patients with locoregional recurrence: a retrospective analysis.
Zhao K; Si Y; Sun L; Meng X; Yu J
Radiat Oncol; 2020 Oct; 15(1):243. PubMed ID: 33087143
[TBL] [Abstract][Full Text] [Related]
11. Primary radiotherapy with or without chemotherapy in non-metastatic esophageal squamous cell carcinoma: a retrospective study.
Fakhrian K; Heilmann J; Schuster T; Thamm R; Reuschel W; Molls M; Geinitz H
Dis Esophagus; 2012 Apr; 25(3):256-62. PubMed ID: 21899651
[TBL] [Abstract][Full Text] [Related]
12. Salvage lymphadenectomy versus salvage radiotherapy/chemoradiotherapy for recurrence in cervical lymph node after curative resection of esophageal squamous cell carcinoma.
Ma X; Zhao K; Guo W; Yang S; Zhu X; Xiang J; Zhang Y; Li H
Ann Surg Oncol; 2015 Feb; 22(2):624-9. PubMed ID: 25155397
[TBL] [Abstract][Full Text] [Related]
13. Prognostic factors of radiotherapy in patients with node-positive thoracic esophageal squamous cell carcinoma after radical surgery.
Lu JC; Tao H; Chen ZZ; Qian PD
Dis Esophagus; 2009; 22(6):490-5. PubMed ID: 19191849
[TBL] [Abstract][Full Text] [Related]
14. The impact of adjuvant radiotherapy on radically resected T3 esophageal squamous cell carcinoma.
Chen SB; Weng HR; Wang G; Liu DT; Li H; Zhang H; Chen YP
J Cancer Res Clin Oncol; 2016 Jan; 142(1):277-86. PubMed ID: 26328915
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of re-irradiation for locoregional esophageal squamous cell carcinoma recurrence after radiotherapy: a systematic review and meta-analysis.
Lan K; Chen J
Radiat Oncol; 2022 Mar; 17(1):61. PubMed ID: 35346285
[TBL] [Abstract][Full Text] [Related]
16. Re-irradiation for local primary-recurrence esophageal squamous cell carcinoma treated with IMRT/VMAT.
Xiang G; Xu C; Chai G; Lyu B; Li Z; Wang B; Shi M; Zhao L
Radiat Oncol; 2023 Jul; 18(1):114. PubMed ID: 37430276
[TBL] [Abstract][Full Text] [Related]
17. Prognostic role of neutrophil-lymphocyte ratio in operable esophageal squamous cell carcinoma.
Duan H; Zhang X; Wang FX; Cai MY; Ma GW; Yang H; Fu JH; Tan ZH; Meng YQ; Fu XY; Ma QL; Lin P
World J Gastroenterol; 2015 May; 21(18):5591-7. PubMed ID: 25987784
[TBL] [Abstract][Full Text] [Related]
18. Preoperative systemic inflammation score (SIS) is superior to neutrophil to lymphocyte ratio (NLR) as a predicting indicator in patients with esophageal squamous cell carcinoma.
Fu X; Li T; Dai Y; Li J
BMC Cancer; 2019 Jul; 19(1):721. PubMed ID: 31331297
[TBL] [Abstract][Full Text] [Related]
19. Dose-escalated re-irradiation improves outcome in locally recurrent head and neck cancer - Results of a large multicenter analysis.
Roesch J; Oertel M; Wegen S; Trommer M; Schleifenbaum J; Hering D; Mäurer M; Knippen S; Dobiasch S; Waltenberger M; von der Grün J; Medenwald D; Süß C; Hoeck M; Käsmann L; Fleischmann DF; Rühle A; Nicolay NH; Fabian A; Löser A; Heß S; Tamaskovics B; Vinsensia M; Hecht M;
Radiother Oncol; 2023 Apr; 181():109380. PubMed ID: 36273736
[TBL] [Abstract][Full Text] [Related]
20. The outcomes of radiotherapy and factors that predict overall survival in elderly patients with esophageal squamous cell carcinoma.
Yin H; E M; Zhang H; Wang C
Clin Transl Oncol; 2017 Jun; 19(6):742-749. PubMed ID: 28091898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
